Deuremidevir hydrobromide
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Deuremidevir hydrobromide, covering 2024-11-20 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children [Phase 3]